News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
697,775 Results
Type
Article (40957)
Company Profile (301)
Press Release (656517)
Section
Business (206728)
Career Advice (2034)
Deals (35609)
Drug Delivery (91)
Drug Development (81789)
Employer Resources (171)
FDA (16218)
Job Trends (15022)
News (348973)
Policy (32923)
Tag
Academia (2631)
Alliances (50022)
Alzheimer's disease (1278)
Approvals (16149)
Artificial intelligence (147)
Bankruptcy (355)
Best Places to Work (11676)
Biotechnology (213)
Breast cancer (169)
Cancer (1303)
Cardiovascular disease (110)
Career advice (1701)
Cell therapy (272)
Clinical research (65197)
Collaboration (444)
Compensation (244)
COVID-19 (2605)
C-suite (112)
Data (1347)
Diabetes (163)
Diagnostics (6263)
Earnings (85187)
Employer resources (149)
Events (111705)
Executive appointments (362)
FDA (16841)
Funding (413)
Gene therapy (196)
GLP-1 (609)
Government (4401)
Healthcare (18954)
Infectious disease (2694)
Inflammatory bowel disease (113)
Interviews (311)
IPO (16390)
Job creations (3740)
Job search strategy (1455)
Layoffs (425)
Legal (8016)
Lung cancer (186)
Manufacturing (197)
Medical device (13326)
Medtech (13331)
Mergers & acquisitions (19339)
Metabolic disorders (434)
Neuroscience (1594)
NextGen Class of 2024 (6593)
Non-profit (4600)
Northern California (1631)
Obesity (253)
Opinion (181)
Patents (113)
People (57728)
Phase I (20284)
Phase II (28702)
Phase III (21394)
Pipeline (500)
Postmarket research (2602)
Preclinical (8706)
Radiopharmaceuticals (237)
Rare diseases (249)
Real estate (6010)
Regulatory (21875)
Research institute (2409)
Resumes & cover letters (353)
Southern California (1419)
Startups (3659)
United States (14739)
Vaccines (569)
Weight loss (179)
Date
Today (150)
Last 7 days (654)
Last 30 days (2961)
Last 365 days (35814)
2024 (34642)
2023 (40522)
2022 (51693)
2021 (56267)
2020 (54638)
2019 (47229)
2018 (35602)
2017 (32703)
2016 (32178)
2015 (38223)
2014 (31924)
2013 (26984)
2012 (29095)
2011 (29763)
2010 (27842)
Location
Africa (740)
Arizona (194)
Asia (37902)
Australia (6220)
California (3667)
Canada (1392)
China (286)
Colorado (165)
Connecticut (172)
Europe (82453)
Florida (507)
Georgia (130)
Illinois (375)
Indiana (217)
Kansas (97)
Maryland (618)
Massachusetts (2884)
Michigan (167)
Minnesota (290)
New Jersey (1057)
New York (1043)
North Carolina (750)
Northern California (1631)
Ohio (144)
Pennsylvania (895)
South America (1121)
Southern California (1419)
Texas (523)
Utah (105)
Washington State (389)
697,775 Results for "manhattan scientifics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Nascent Biotech and Manhattan BioSolutions Collaborate to Explore Pritumumab Antibody-Drug Conjugates
Nascent Biotech, Inc. (OTCQB:NBIO) (“Nascent Biotech”, “Nascent”), announced today it has entered into a research collaboration agreement with Manhattan BioSolutions, Inc. (Manhattan Bio), an emerging biotech company focused on precision biologics, to explore antibody-drug conjugates (ADCs) using Nascent’s lead clinical candidate pritumumab (PTB) as the tumor-targeting antibody element.
February 6, 2024
·
4 min read
Pharm Country
Manhattan Scientifics Celebrates Imagion Biosystems’ Milestones in Early Cancer Detection Technology
Manhattan Scientifics Inc. (OTCQB: MHTX), which provided the initial funding &, currently owns more than 50 million shares of Imagion Biosystems Ltd. celebrates Imagion’s remarkable progress in early cancer detection technology.
May 31, 2023
·
2 min read
Press Releases
Boston Scientific Closes Acquisition of Axonics, Inc.
November 15, 2024
·
5 min read
Press Releases
Boston Scientific Announces Agreement to Acquire Intera Oncology® Inc.
November 25, 2024
·
7 min read
Deals
Boston Scientific Announces Agreement to Acquire Silk Road Medical, Inc.
Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Silk Road Medical, Inc.
June 18, 2024
·
7 min read
Press Releases
Boston Scientific Announces Agreement to Acquire Cortex, Inc.
November 5, 2024
·
7 min read
Press Releases
Adnexus Biotechnologies Inc. Appoints Dr. Hiroshi Ohrui to Scientific Advisory Board
November 19, 2024
·
3 min read
Reflect Scientific Inc Secures $550,000 Sale with Major BioPharma Company
Reflect Scientific, Inc. is pleased to announce a significant sale of its cutting-edge freezer systems to a major biopharmaceutical company.
April 30, 2024
·
3 min read
Pharm Country
Scientific Industries Announces Industry Veteran, John Nicols, as New Board Member and Chairman of Scientific Bioprocessing Inc.
Scientific Industries, Inc. announced the appointment of John Nicols to the Board of Directors of SI and Chairman of its wholly, owned subsidiary, Scientific Bioprocessing Inc., effective March 4, 2024.
March 8, 2024
·
4 min read
Biotech Bay
Avirmax Inc. to Make Scientific Presentations at ASGCT in Baltimore
Avirmax Inc., will make two scientific presentations at the upcoming American Society of Gene and Cell Therapy (ASGCT) annual meeting in Baltimore between May 7th and 11th, 2024.
April 16, 2024
·
2 min read
1 of 69,778
Next
